Struggling AlloVir finds new identity by merging into eye disease biotech jwaldron Fri, 11/08/2024 - 08:04
Dynavax drops Tdap vaccine after considering phase 1 data, competition jwaldron Fri, 11/08/2024 - 05:44
Dig into this year’s Fierce Biotech Graveyard, layoff numbers aellison Tue, 11/05/2024 - 16:01
Nkarta continues pivot to autoimmune by shelving lymphoma program for CAR NK candidate jwaldron Fri, 11/08/2024 - 04:56
Chutes & Ladders—Trevena teeters on edge with C-suite shakedown dincorvaia Thu, 11/07/2024 - 15:37
Carisma's Moderna-powered in vivo macrophage cell therapy shrinks lung and liver tumors in mice dincorvaia Thu, 11/07/2024 - 13:07
Vytvořte si vlastní zdroj
Jste připraveni to vyzkoušet?
Spusťte 14denní zkušební verzi bez nutnosti platební karty.